Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
Tumori|April 13, 2021
Clinical predictors for biochemical failure in patients with positive surgical margin after robotic-assisted radical prostatectomyShih-Huan Su, Ying-Hsu Chang, Liang-Kang Huang, et al.
Journal of Cancer Research and Clinical Oncology|October 7, 2025
Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from TaiwanWen-Kuan Huang, Po-Jung Su, Chun-Chi Chen, et al.
American Journal of Cancer Research|September 13, 2024
Paraneoplastic leukocytosis induces NETosis and thrombosis in bladder cancer PDX modelYung-Chia Kuo, Chen-Yang Huang, Cedric Chuan Young Ng, et al.
The Journal of Pathology|October 3, 2024
Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockadePo-Hung Lin, Jason Yongsheng Chan, Peiyong Guan, et al.
Molecular Oncology|August 6, 2014
Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysisCheng-Lung Hsu, Jai-Shin Liu, Po-Long Wu, et al.
Cancer Management and Research|November 17, 2022
Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG DiscontinuationPo-Ting Lin, Ming-Li Hsieh, Shih-Huan Su, et al.
BMC Medical Imaging|February 26, 2025
Using deep learning to differentiate among histology renal tumor types in computed tomography scansHung-Cheng Kan, Po-Hung Lin, I-Hung Shao, et al.
Cancer Medicine|November 9, 2024
Nomogram Analysis for Predicting Response to Androgen-Receptor-Axis-Targeted Therapies in Patients With Metastatic Castration-Resistant Prostate CancerI-Hung Shao, Hsiang-Shen Wang, Chin-Hsuan Hsieh, et al.
Biomedicines|January 21, 2022
Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial CarcinomaChung-Ying Tsai, Hsiang-Cheng Chi, Ren-Chin Wu, et al.
Investigative and Clinical Urology|September 6, 2022
Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancerChung-Lin Lee, Ying-Hsu Chang, Chung-Yi Liu, et al.
Pageof 20